)
Lipum (LIPUM) investor relations material
Lipum Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Advanced to phase 2 clinical development for SOL-116 targeting rheumatoid arthritis, following successful phase 1 results and new scientific data supporting BSSL as a biomarker.
Announced a proposed merger with main shareholder Flerie to secure long-term financing and access to broader resources.
89% participation in new employee and board stock option programs; new CFO appointed.
Financial highlights
Operating income for Q3: 457 KSEK (109 KSEK year-over-year), mainly from grants.
Operating loss for Q3: -13,144 KSEK (-1,632 KSEK year-over-year); net loss after financial items: -14,027 KSEK (-1,680 KSEK year-over-year).
Cash and cash equivalents at period end: 5,627 KSEK (12,873 KSEK year-over-year).
Cash flow from operations Q3: -7,730 KSEK (-7,258 KSEK year-over-year); financing inflow of 11,683 KSEK from loans and options.
Outlook and guidance
Additional financing required to initiate phase 2 study in H1 2026; merger with Flerie expected to secure necessary capital.
Ongoing scientific collaborations and clinical progress support continued development of SOL-116.
- Mitazalimab shows significant survival gains in pancreatic cancer, with phase III trials imminent.LIPUM
Investing in Life Science 20258 Dec 2025 - Phase 1 success for SOL-116 enables phase 2 plans, but further funding and risk management are critical.LIPUM
Q2 202528 Aug 2025 - Phase 1 trial for SOL-116 nearly complete; strong cash position but further funding required.LIPUM
Q3 202413 Jun 2025 - Phase 1 for SOL-116 nearly complete; strong liquidity and positive interim results support phase 2.LIPUM
Q2 202413 Jun 2025 - Phase 1 success for SOL-116 sets stage for phase 2, but further funding is required.LIPUM
Q1 20255 Jun 2025 - Phase 1 success for SOL-116 and new funding set stage for Lipum's phase II ambitions.LIPUM
Q4 20245 Jun 2025
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)